Infertility Clinical Trial
Official title:
The Comparison of TAP Block and QL Block on Postoperative Analgesic Consumption and Patient Satisfaction After Varicocele Surgery
In this study we aim to compare the effect of TAP block and QL block on postoperative
analgesia, analgesic consumption , side effects and patient satisfaction after varicocelec
surgery.
75 patients will be randomized into 3 groups:TAP Group (Group T) n = 25, QL Group (Group Q) n
= 25, Control Group (Group K) n = 25 All patients will be operated on with spinal anesthesia.
TAP and QL blocks will be performed after completion of the surgeries. In the postoperative
care unit, an iv patient-controlled analgesia protocol with tramadol will be started.
Patients in all three groups will be assessed with a resting and cough VAS (visual analog
scale) at postoperative 2,4,6,12,18 and 24 hours and values will be recorded. The amount of
analgesic consumption and the first analgesic request times will be recorded. Post-operative
QUIPS: Quality Improvement in Postoperative Pain Management questionnaire will be applied,
side effects such as nausea-vomiting, drowsiness will be noted. In addition, patient
satisfaction will be assessed with these methods as bad, medium, good, and very good.
Purpose:TAP is the application of local anesthetic agents to block the anterior neck of the
thoracic intercostal (T7-T12) and first lumbar (L1) nerves in the anatomic neurofascial gap
between the internal oblique and transversus abdominis muscle located in the anterolateral
region of the abdomen. It was first described by Rafi in 2001. Then in 2007 Hebbart et al.
described that using USG, TAP block could be implemented more effectively and safely. With QL
block, a local anesthetic agent is applied to the posterior layer of the thoracolumbar fascia
and similar nerve blockage is achieved. The technique was first described by Blanco in 2007.
TAP block and QL block may be a good method for postoperative pain control. We aimed to
compare the efficacy of TAP block and QL block to analgesic consumption after varicocelectomy
operations, analgesic side effects and analgesia quality and to compare these two block
efficacy.
Material & Method:75 patients in the ASA I-II risk group, aged 18-45 years, who will undergo
elective varicocelectomy surgery, will be randomized using the cohort procedure. The patient
will be informed about the study and will be included in the study after the patient is
approved with the approval form. The three groups will be divided into TAP Group (Group T) n
= 25, QL Group (Group Q) n = 25, Control Group (Group K) n = 25. A total of 75 patients were
planned to receive α = 0,05 at the β: 0.20 level and 0.80 at the power level and n = 25 for
each group. Reference work including VAS scores and I-TAP method was taken into consideration
when the sample size of the study was determined. The normal distribution of data in the
statistical evaluation of the study will be examined by the Shapiro-Wilk test. One-way ANOVA
will be performed for comparison of groups (if the data are normally distributed). Multiple
comparisons Tukey test, Dunnett test Tamhane T2 test will be applied. (Kruskal-Wallis H test
will be applied in cases where it does not normally disperse.) Multiple comparison will be
performed with the Dunn-Sidak test. Statistical significance is accepted as p <0.05, data
will be examined in the IBMSPSS program. All three patients will be operated on with spinal
anesthesia. Patients with coagulopathy who are contraindicated for spinal anesthesia, known
allergies to the drugs to be used, infected and non-voluntary patients to be excluded from
the study. At the end of the disease operation in Group T, after the necessary antiseptic
conditions are established in the supine position, the USG probe midpoint (within the petit
triangle). After the abdominal muscle layers are seen, the facial muscle sensation is taken
when the needle-like muscular layers and facial muscles pass, and the needle is controlled
with USG. After receiving the second click feeling (passage of the internalocutaneous
fascia), the needle-like localization will be determined by applying a test dose of 0.5-1 ml.
After localization is confirmed, frequent aspiration and local anesthetic agent will be given
to the neurophysiologic plan and TAP block will be applied. To apply the lateral QL block to
the patient in Group Q, a low frequency convex probe is inserted into the patient while the
patient is in the supine position. Quadratus lumborum block 1 is injected with 20 mL of local
anesthetic on the lateral side of the QL muscle in the area where the transversus abdominis
muscle contacts the transversal fascia at the level that enters the aponeurope. Local
analgesics will not be administered with Group III disease needle. When the patient is
removed to the postoperative care unit, an iv patient-controlled analgesia device will be
applied. Patients in all three groups will be assessed with a resting and cough VAS (visual
analog scale) at postoperative 2,4,6,12,18 and 24 hours (pain intensity: 0 no pain and 10:
the most severe pain I have ever heard) and values will be recorded. When the patient has a
pain, an analgesic agent will be given according to the patient-controlled analgesia
protocol. The amount of analgesic agent consumed by the patients when the first analgesic
agent is needed and 24 hours will be recorded. Post-operative QUIPS: Quality Improvement in
Postoperative Pain Management questionnaire will be applied, side effects such as
nausea-vomiting, drowsiness will be noted. In addition, patient satisfaction will be assessed
with these methods as bad, medium, good, and very good.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A |